Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Audit and Feedback for General Practitioners in the Intego Network

8 de março de 2022 atualizado por: Tine De Burghraeve

Audit and feedback is an extensively investigated quality intervention, which according to the last Cochrane review leads to small but potentially important improvements in professional practice. There is some evidence that feedback can improve EHR registration but the effect and important features of feedback are still the subject of debate. Previous work has identified some testable and theory-informed hypotheses for designing an audit and feedback intervention and suggestions to improve the effectiveness of the intervention are available in literature. There are several criteria feedback could meet to have an impact on the registration level of GP's in the EHR. The researchers now want to evaluate if the effort to make an extended feedback intervention has an effect on the registration behavior of the GP.

The research question is: Does an audit and extended feedback intervention improves the quality of registration in the EHR of the general physician compared to basic feedback?

Visão geral do estudo

Descrição detalhada

Intego is a Belgian general practice-based morbidity registration network at the Department of General Practice of the University of Leuven. Intego collects data on health parameters, incidence and prevalence rates, laboratory results, and prescribed drugs for all relevant subgroups. It is unique in Belgium. These data are used as a basis for teaching, quality improvement interventions, and research, as well as for policy making by both physicians' organizations and governmental bodies. The health ministry of the Flemish government mainly funds the network. Ad hoc research projects serve as an additional funding source.

Up until 2017, 97 general practitioners (GP's) of 55 practices evenly spread throughout Flanders, Belgium, collaborated in Intego. GP's applied for inclusion in the registry. Before acceptance of their data, registration performance was audited using algorithms to compare their results with those of all other applicants. Only data of practices with optimal registration performance that met our three quality requirements were included in the database. First, the average number of new diagnoses per patient per year should be higher than one. Second, diagnoses have to be entered in the practice software using keywords. The Intego GP's prospectively and routinely registered all new diagnoses and new drug prescriptions, as well as laboratory test results and patient information. The registration made use of computer-generated keywords internally linked to codes [International Classification of Primary Care (ICPC-2) and International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) for diagnoses and WHO's Anatomical Therapeutic Chemical (ATC) classification system for drugs]. The percentage of diagnoses recorded without using keywords should be less than 5%. Finally, these parameters must remain stable for at least three years.

In 2017, Intego made a transition in data infrastructure and size of the network.

Further information technology development for the electronic health record (EHR) 'Medidoc' was terminated, and all its users were urged by the vendor to migrate to a new EHR, called CareConnect (Corilus), a cloud-based EHR. This transition marked the moment to redesign the data collection for this registry, which had not changed since its start. To comply with the new General Data Protection Regulation legislation, the Healthdata.be platform was identified as a partner for this task.

Moreover, the number of practices was increased and now counts 107 practices (410 GPs). However, new GP practices might not meet the quality requirements for good registration yet.

The data completeness of the EHR is thus an important factor to consider when reusing data stored in the EHR. Other pitfalls and sources of bias when using EHR data have also been identified. In order to improve registration, we want to implement extended electronically delivered feedback and evaluate its effects on correctly registering the diagnosis of chronic diseases and lifestyle habits in the EHR.

Audit and feedback is an extensively investigated quality intervention, which according to the last Cochrane review leads to small but potentially important improvements in professional practice. There is some evidence that feedback can improve EHR registration but the effect and important features of feedback are still the subject of debate. Previous work has identified some testable and theory-informed hypotheses for designing an audit and feedback intervention and suggestions to improve the effectiveness of the intervention are available in literature. There are several criteria feedback could meet to have an impact on the registration level of GP's in the EHR. We now want to evaluate if the effort to make an extended feedback intervention has an effect on the registration behavior of the GP.

The research question is: Does an audit and extended feedback intervention improves the quality of registration in the EHR of the general physician compared to basic feedback?

Tipo de estudo

Intervencional

Estágio

  • Não aplicável

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

inclusion criteria:

  • This trial has the general practices as the level of allocation.
  • All GPs in the Intego network will be asked to participate in this trial.
  • For GPs working in a group, the whole group will be asked to collaborate.

Exclusion criteria:

- If not all GPs in a group practice want to collaborate in the intervention study, the whole GP practice will not be included in this study.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Extended audit and feedback

The intervention consists of an extended electronically delivered feedback with multiple components which will be delivered 4 times electronically into general practices over 12 months.

This extended feedback report consists of:

  • Benchmarking of the results of the audit versus peers, versus guidelines and versus disease specific laboratory results.
  • A low cognitive load of the feedback where the results will be presented with the help of graphs.
  • Action plans to improve the quality of registration
  • A push system to minimize the effort the GP must make to consult the feedback.

The intervention consists of an extended electronically delivered feedback with multiple components which will be delivered 4 times electronically into general practices over 12 months.

This extended feedback report consists of:

  • Benchmarking of the results of the audit versus peers, versus guidelines and versus disease specific laboratory results.
  • A low cognitive load of the feedback where the results will be presented with the help of graphs.
  • Action plans to improve the quality of registration
  • A push system to minimize the effort the GP must make to consult the feedback.
Comparador Ativo: Basic feedback
In the past, all GPs received basic feedback on the level of registration in the EHR and this form of feedback will still be provided in the control group. By providing all GPs a basic level of feedback, we do not change the former protocol and all GPs will receive the opportunity to improve their registration performance. Only the way of receiving feedback is more straightforward, the GP needs to login to HealthStat.be.

The intervention consists of an extended electronically delivered feedback with multiple components which will be delivered 4 times electronically into general practices over 12 months.

This extended feedback report consists of:

  • Benchmarking of the results of the audit versus peers, versus guidelines and versus disease specific laboratory results.
  • A low cognitive load of the feedback where the results will be presented with the help of graphs.
  • Action plans to improve the quality of registration
  • A push system to minimize the effort the GP must make to consult the feedback.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
percentage registered diagnoses of DM 2 in the EHR
Prazo: 12 months
Registered diagnosis of type II diabetes in GPs electronic health record
12 months

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Percentage registered lifestyle factors
Prazo: 12 months
Registration of lifestyle habits such as alcohol and tobacco use
12 months
percentage registered diagnoses of heart failure
Prazo: 12 months
Registered diagnosis of heart failure in GPs electronic health record
12 months

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
CKD follow-up quality indicator
Prazo: 12 months
Percentage of patients with CKD in whom the GFR, albuminuria and total protein is determined at least once a year
12 months
CKD vaccination quality indicator
Prazo: 12 months
Percentage of patients with CKD who received a pneumococcal vaccination
12 months
Diabetes treatment quality indicator
Prazo: 12 months
Percentage of patients with diabetes and CKD who no longer receive metformin
12 months
Diabetes follow-up quality indicator
Prazo: 12 months
Percentage of patients with diabetes whose HbA1c level is measured at least once every 6 months
12 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Tine De Burghgraeve, PhD, KU Leuven

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

30 de janeiro de 2022

Conclusão Primária (Real)

28 de fevereiro de 2022

Conclusão do estudo (Real)

28 de fevereiro de 2022

Datas de inscrição no estudo

Enviado pela primeira vez

11 de maio de 2020

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de maio de 2020

Primeira postagem (Real)

14 de maio de 2020

Atualizações de registro de estudo

Última Atualização Postada (Real)

22 de março de 2022

Última atualização enviada que atendeu aos critérios de controle de qualidade

8 de março de 2022

Última verificação

1 de março de 2022

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • S62753

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever